CD8A and HIV infectious disease: In summary, we made use of a potent TCR-anti-CD3 bispecific molecule to demonstrate IS formation between primary HIV-infected CD4 + T cells and polyclonal CD8+ T cells from individuals with treated chronic HIV infection.